Facilitated By

San Antonio Medical Foundation

News

  • Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in ... - BioSpace

    ... San Antonio Breast Cancer Symposium. December ... Celcuity is a clinical-stage biotechnology ... Vector Illustration of pharmacy drug health tablet ...

  • Holland & Knight Expands Intellectual Property Group with Addition of Partner Kenneth ...

    His practice covers various industries, including biotech ... degree in physiology from The University of Texas Health Science Center at San Antonio and ...

  • ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at ...

    ... biotechnology company advancing therapies that ... The data were featured today in a spotlight poster presentation at the 2024 San Antonio Breast Cancer ...

  • TerSera® Presents New Real-World Evidence on Treatment Outcomes of Goserelin ... - BioSpace

    These data were presented in a poster session at the 2024 San Antonio Breast Cancer Symposium, held December 10-13 in San Antonio, TX.1 A copy of ...

  • US appeals court rejects Nasdaq's diversity rules for company boards

    Brooklynn Chandler Willy, CEO and president of San Antonio-based Texas Financial Advisory,. Business · IRS arrests S.A. investment adviser, radio host ...